SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD

Autres langues Shanghai Labway Clinical Laboratory Co., Ltd

Actions

301060

CNE100004RG8

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 18/04/2024			Varia. 5j.	Varia. 1 janv.
9,07 ^CNY	-3,30 %		-16,17 %	-31,75 %

2023	Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) annonce un rachat d'actions pour une valeur de 30 millions CNY.	CI
2023	Shanghai Labway Clinical Laboratory Co. autorise un plan de rachat.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tranche Update on Shanghai Labway Clinical Laboratory Co., Ltd's Equity Buyback Plan announced on November 16, 2023.	03/04
Tranche Update on Shanghai Labway Clinical Laboratory Co., Ltd's Equity Buyback Plan announced on November 16, 2023.	04/01
Shanghai Labway Clinical Laboratory Co., Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	16/11
Shanghai Labway Clinical Laboratory Co., Ltd authorizes a Buyback Plan.	11/11
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Certain A Shares of Shanghai Labway Clinical Laboratory Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-SEP-2023.	14/09/23
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Labway Clinical Laboratory to Buy Enterprise Management Firm For 283 Million Yuan	10/07/23
Shanghai Labway Clinical Laboratory Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023	14/06/23
Shanghai Labway Clinical Laboratory Co., Ltd Approves Cash Dividend for 2022	29/05/23
Shanghai Labway Clinical Laboratory Co., Ltd Proposes Final Cash Dividend for the Year 2022	27/04/23
Shanghai Labway Clinical Laboratory Co., Ltd cancelled the transaction announced on September 1, 2022	27/04/23
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	19/04/23
As China seeks to live with the virus, COVID-control industries face decline	16/12/22
Chinese COVID testing firms report big profits as virus fight intensifies	03/11/22
Shanghai Labway Clinical Laboratory Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Shanghai Labway Clinical Laboratory Co., Ltd.(XSEC:301060) added to S&P Global BMI Index	19/09/22
Certain A Shares of Shanghai Labway Clinical Laboratory Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-SEP-2022.	14/09/22
Shanghai Labway Plans $96 Million Share Sale to Fund New Laboratories	05/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Shanghai Labway Clinical Laboratory Co., Ltd

Actions

301060

CNE100004RG8

Autres langues

Filtres